BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 11457475)

  • 1. Opsonization of yeast cells with equine iC3b, C3b, and IgG.
    Gröndahl G; Johannisson A; Jensen-Waern M; Nilsson Ekdahl K
    Vet Immunol Immunopathol; 2001 Aug; 80(3-4):209-23. PubMed ID: 11457475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
    Newman SL; Mikus LK
    J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of C3b deposition on yeast surfaces by sera of known opsonic potential.
    Turner MW; Mowbray JF; Roberton DR
    Clin Exp Immunol; 1981 Nov; 46(2):412-9. PubMed ID: 7039889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
    Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
    Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of complement receptor type three and serum opsonins in the neutrophil response to yeast.
    Cain JA; Newman SL; Ross GD
    Complement; 1987; 4(2):75-86. PubMed ID: 3040333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human serum induced opsonization of immunoglobulin G-coated polystyrene microspheres with complement components C3 and C4 as measured by flow cytometry.
    Spycher MO; Spycher-Burger M; Späth PJ; Burckhardt JJ
    J Immunol Methods; 1991 Dec; 145(1-2):83-92. PubMed ID: 1765669
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sharma S; Bhatnagar R; Gaur D
    Front Immunol; 2020; 11():462. PubMed ID: 32296419
    [No Abstract]   [Full Text] [Related]  

  • 8. Activation, binding, and processing of complement component 3 (C3) by Blastomyces dermatitidis.
    Zhang MX; Klein B
    Infect Immun; 1997 May; 65(5):1849-55. PubMed ID: 9125571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization.
    Gordon DL; Rice J; Finlay-Jones JJ; McDonald PJ; Hostetter MK
    J Infect Dis; 1988 Apr; 157(4):697-704. PubMed ID: 3279137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age and plasma treatment on neutrophil phagocytosis and CD18 expression in foals.
    Gröndahl G; Johannisson A; Demmers S; Jensen Waern M
    Vet Microbiol; 1999 Mar; 65(3):241-54. PubMed ID: 10189199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b.
    Ross GD; Cain JA; Lachmann PJ
    J Immunol; 1985 May; 134(5):3307-15. PubMed ID: 2984286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of C3 by a casein kinase released from activated human platelets increases opsonization of immune complexes and binding to complement receptor type 1.
    Nilsson-Ekdahl K; Nilsson B
    Eur J Immunol; 2001 Apr; 31(4):1047-54. PubMed ID: 11298329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of opsonins in vacuolar sealing and the ingestion of zymosan by human neutrophils.
    Kemp AS; Turner MW
    Immunology; 1986 Sep; 59(1):69-74. PubMed ID: 3759128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonization of encapsulated Staphylococcus aureus: the role of specific antibody and complement.
    Verbrugh HA; Peterson PK; Nguyen BY; Sisson SP; Kim Y
    J Immunol; 1982 Oct; 129(4):1681-7. PubMed ID: 7108223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suboptimal C3b/C3bi deposition and defective yeast opsonization. I. Evidence for the absence of essential co-factor activity.
    Turner MW; Seymour ND; Kazatchkine MD; Mowbray JF
    Clin Exp Immunol; 1985 Nov; 62(2):427-34. PubMed ID: 2935338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
    Weis JJ; Law SK; Levine RP; Cleary PP
    J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway.
    Yuste J; Sen A; Truedsson L; Jönsson G; Tay LS; Hyams C; Baxendale HE; Goldblatt F; Botto M; Brown JS
    Infect Immun; 2008 Aug; 76(8):3761-70. PubMed ID: 18541650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonins in uterine washings influencing in vitro activity of equine neutrophils.
    Watson ED
    Equine Vet J; 1988 Nov; 20(6):435-7. PubMed ID: 3063522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement C3 opsonization of Chlamydia trachomatis facilitates uptake in human monocytes.
    Lausen M; Christiansen G; Karred N; Winther R; Poulsen TBG; Palarasah Y; Birkelund S
    Microbes Infect; 2018; 20(6):328-336. PubMed ID: 29729435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.